Clearmind Medicine Inc (CMND)
1.23
-0.06
(-4.65%)
USD |
NASDAQ |
May 17, 16:00
1.23
0.00 (0.00%)
After-Hours: 20:00
Clearmind Medicine Shareholders Equity (Quarterly): 5.041M for Jan. 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 5.041M |
| October 31, 2023 | 0.7111M |
| July 31, 2023 | 2.133M |
| April 30, 2023 | 2.447M |
| January 31, 2023 | 3.842M |
| October 31, 2022 | -0.8127M |
| July 31, 2022 | 0.2803M |
| April 30, 2022 | 1.414M |
| January 31, 2022 | 2.404M |
| October 31, 2021 | 3.875M |
| July 31, 2021 | 5.307M |
| April 30, 2021 | 1.577M |
| Date | Value |
|---|---|
| January 31, 2021 | 0.3134M |
| October 31, 2020 | 0.3748M |
| July 31, 2020 | 0.4282M |
| April 30, 2020 | 0.4649M |
| January 31, 2020 | 0.0824M |
| October 31, 2019 | 0.1016M |
| July 31, 2019 | 0.1208M |
| April 30, 2019 | 0.1341M |
| January 31, 2019 | 0.165M |
| October 31, 2018 | 0.1822M |
| July 31, 2018 | 0.1426M |
| April 30, 2018 | 0.1799M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.8127M
Minimum
Oct 2022
5.307M
Maximum
Jul 2021
1.584M
Average
0.7111M
Median
Oct 2023
Shareholders Equity (Quarterly) Benchmarks
| SciSparc Ltd | 7.614M |
| ImmunoPrecise Antibodies Ltd | 37.17M |
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.10M |
| Total Liabilities (Quarterly) | 5.056M |